Clinical Trial Update: Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating spironolactone for efficacy in rheumatoid arthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Rheumatoid Arthritis | Phase 3 | Status: RECRUITING